Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours

Journal of Pathology

Volumn 214, Issue 1, 2008, Pages 58-64

  Franco, R ^a   Esposito, F ^b   Fedele, M ^b,c   Liguori, G ^a   Pierantoni, G M ^b   Botti, G ^a   Tramontano, D ^b   Fusco, A ^b,d   Chieffi, P ^b,e  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c CNR   (Italy)

^d CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^e Dipartimento di Medicina Sperimentale   (Italy)

Author keywords

Fertility; HMGA proteins; Spermatogenesis; Testicular tumours; Testis

Indexed keywords

HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP A1 PROTEIN; HIGH MOBILITY GROUP A2 PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EMBRYONAL CARCINOMA; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MIXED TUMOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PUBERTY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMINOMA; TERATOMA; TESTIS TUMOR; TUMOR DIAGNOSIS; TUMOR DIFFERENTIATION; WESTERN BLOTTING; YOLK SAC TUMOR;

ADULT; BLOTTING, WESTERN; GENE EXPRESSION; HMGA1A PROTEIN; HMGA2 PROTEIN; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS, GERM CELL AND EMBRYONAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 38049086953     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2249     Document Type: Article

References (21)

1. Oosterhuis JW, Looijenga LH. Testicular germ-cell tumors in a broader perspective. Nat Rev Cancer 2005;5:210-222.
2. Chieffi P. Molecular targets for the treatment of testicular germ cell tumors. Mini-Rev Med Chem 2007;7:755-759.
3. Johnson KR, Lehn DA, Reeves R. Alternative processing of mRNAs coding for human HMGI and HMGY proteins. Mol Cell Biol 1989;9:2114-2123.
4. Fedele M, Battista S, Manfioletti G, Croce CM, Giancotti V, Fusco A. Role of the high mobility group A proteins in human lipomas. Carcinogenesis 2001;22:1583-1591.
5. Thanos D, Maniatis T. The high mobility group protein HMGI(Y) is required for NF-κB-dependent virus induction of human-β gene. Cell 1992;71:777-789.
6. Zhou X, Benson KF, Ashar HR, Chada KK. Mutation responsible for the mouse pygmy phenotype in developmentally regulated factor HMGI-C. Nature 1995;376:771-774.
7. Battista S, Fidanza M, Fedele M, Klein-Szanto AJ, Outwater E, Brunner H, et al. The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res 1999;59:4793-4797.
8. Berlingeri MT, Manfioletti G, Santoro M, Bandiera A, Visconti R, Giancotti V, et al. Inhibition of HMG-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol 1995;15:1545-1553.
9. Scala S, Portella G, Fedele M, Chiappetta G, Fusco A. Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias. Proc Natl Acad Sci USA 2000;97:4256-4261.
10. Wood LJ, Maher JF, Bunton TE, Resar LM. The oncogenic properties of the HMG-I gene family. Cancer Res 2000;60:4256-4261.
11. Baldassarre G, Fedele M, Battista S, Vecchione A, Klein-Szanto AJ, Santoro M, et al. Onset of natural killer cell lymphomas in transgenic mice carryng a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc Natl Acad Sci USA 2001;98:7970-7975.
12. Fedele M, Visone R, De Martino I, Troncone G, Palmieri D, Battista S, et al. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 2006;9:459-471.
13. Fedele M, Pentimalli F, Baldassarre G, Battista S, Klein-Szanto AJ, Kenyon L, et al. Transgenic mice over-expressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. Oncogene 2005;24:3427- 3435.
14. Chieffi P, Battista S, Barchi M, Di Agostino S, Pierantoni GM, Fedele M, et al. HMGA1 and HMGA2 protein expression in mouse spermatogenesis. Oncogene 2002;21:3544-3550.
15. Di Agostino S, Fedele M, Chieffi P, Fusco A, Rossi P, Geremia R, et al. Phosphorylation of high-mobility group protein A2 by Nek2 kinase during the first meiotic division in mouse spermatocytes. Mol Biol Cell 2004;15:1224-1232.
16. Pierantoni GM, Rinaldo C, Mottolese M, Di Benedetto A, Esposito F, Soddu S, et al. High mobility group A1 inhibits P53 by cytoplasmic relocalization of its proapoptotic activator HIPK2. J Clin Invest 2006;117:693-702.
17. Reuter VE. Origins and molecular biology of testicular germ cell tumors. Mod Pathol 2005;18:S51-60.
18. Ulbright TM. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol 2005;18:S61-79.
19. Ulbright TM, Young RH. Seminoma with tubular, microcystic, and related patterns: a study of 28 cases of unusual morphologic variants that often cause confusion with yolk sac tumor. Am J Surg Pathol 2005;29:500-505.
20. Moran CA, Travis WD, Carter D, Koss MN. Metastatic mature teratoma in lung following testicular embryonal carcinoma and teratocarcinoma. Arch Pathol Lab Med 1993;117:641-644.
21. Theaker JM, Mead GM. Diagnostic pitfalls in the histopathological diagnosis of testicular germ cell tumours. Curr Diagn Pathol 2004;10:220-228.